CIK 0002088082 · <br>Emerging growth company
Electra Therapeutics, Inc.
Sign in to watch- Ticker
- ETRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832193635
- Phone
- (888) 743-2290
- Business address
- 230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $48,699,284
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$48,699,284. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | GORDON CARL L Director | Purchase | +20,700 | $8.45 | $175K | 5,255,278 |
| 2026-11-10 | GORDON CARL L Director | Purchase | +2,000 | $8.45 | $17K | 2,194,579 |
| 2026-11-10 | ORBIMED ADVISORS LLC Director | Purchase | +20,700 | $8.45 | $175K | 5,255,278 |
| 2026-11-10 | ORBIMED ADVISORS LLC Director | Purchase | +2,000 | $8.45 | $17K | 2,194,579 |
| 2026-11-09 | GORDON CARL L Director | Purchase | +4,000 | $8.24 | $33K | 5,234,578 |
| 2026-11-09 | GORDON CARL L Director | Purchase | +16,000 | $8.24 | $132K | 2,192,579 |
| 2026-11-09 | ORBIMED ADVISORS LLC Director | Purchase | +4,000 | $8.24 | $33K | 5,234,578 |
| 2026-11-09 | ORBIMED ADVISORS LLC Director | Purchase | +16,000 | $8.24 | $132K | 2,192,579 |
| 2026-11-06 | GORDON CARL L Director | Purchase | +9,816 | $7.85 | $77K | 5,230,578 |
| 2026-11-06 | GORDON CARL L Director | Purchase | +39,600 | $7.85 | $311K | 2,176,579 |
| 2026-11-06 | ORBIMED ADVISORS LLC Director | Purchase | +9,816 | $7.85 | $77K | 5,230,578 |
| 2026-11-06 | ORBIMED ADVISORS LLC Director | Purchase | +39,600 | $7.85 | $311K | 2,176,579 |
| 2026-11-05 | GORDON CARL L Director | Purchase | +30,891 | $7.31 | $226K | 5,220,762 |
| 2026-11-05 | GORDON CARL L Director | Purchase | +125,200 | $7.31 | $915K | 2,136,979 |
| 2026-11-05 | ORBIMED ADVISORS LLC Director | Purchase | +30,891 | $7.31 | $226K | 5,220,762 |
| 2026-11-05 | ORBIMED ADVISORS LLC Director | Purchase | +125,200 | $7.31 | $915K | 2,136,979 |
| 2026-11-04 | GORDON CARL L Director | Purchase | +9,267 | $7.78 | $72K | 5,184,871 |
| 2026-11-04 | GORDON CARL L Director | Purchase | +37,100 | $7.78 | $289K | 1,991,779 |
| 2026-11-04 | GORDON CARL L Director | Purchase | +5,000 | $7.07 | $35K | 5,189,871 |
| 2026-11-04 | GORDON CARL L Director | Purchase | +20,000 | $7.07 | $141K | 2,011,779 |
Page 1 of 3 · 60 trades